Skip to main content

Table 1 Baseline characteristics

From: Proposal for the use of echocardiography in bloodstream infections due to different streptococcal species

 

Low-risk Streptococci

(n = 3230)

Moderate-risk streptococci

(n = 2106)

High-risk streptococci

(n = 556)

Very high-risk streptococci

(n = 501)

All BSIs

(N = 6393)

Demographics

 Age, mean (SD)

66.8 (16.5)

69.4 (15.6)

67.0 (17.1)

72.2 (14.2)

68.1 (16.2)

 Male, n (%)

1543 (47.8)

1204 (57.2)

325 (58.5)

301 (60.1)

3373 (52.8)

Comorbidities a

 Native valve disease b, n (%)

97 (3.0)

106 (5.0)

38 (6.8)

66 (13.2)

307 (4.8)

 Prosthetic valve, n (%)

47 (1.5)

61 (2.9)

28 (5.0)

62 (12.4)

198 (3.1)

 Previous IE, n (%)

23 (0.7)

34 (1.6)

12 (2.2)

22 (4.4)

91 (1.4)

 Cardiac device c, n (%)

120 (3.7)

101 (4.8)

26 (4.7)

46 (9.2)

293 (4.6)

 IHD, n (%)

478 (14.8)

428 (20.3)

128 (23.0)

138 (27.5)

1172 (18.3)

 CHF, n (%)

365 (11.3)

347 (16.5)

89 (16.0)

123 (24.6)

924 (14.5)

 Cancer, n (%)

787 (24.4)

671 (31.9)

162 (29.1)

130 (25.9)

1750 (27.4)

 COPD, n (%)

612 (18.9)

280 (13.3)

105 (18.9)

86 (17.2)

1083 (16.9)

 DM, n (%)

386 (12.0)

372 (17.7)

84 (15.1)

101 (20.2)

943 (14.8)

 Renal disease, n (%)

230 (7.1)

209 (9.9)

64 (11.5)

57 (11.4)

560 (8.8)

 Renal dialysis, n (%)

44 (1.4)

40 (1.9)

13 (2.3)

15 (3.0)

112 (1.8)

  1. BSI Bloodstream infection, CHF Congestive heart failure, COPD Chronic obstructive pulmonary disease, DM Diabetes mellitus, IE Infective endocarditis, IHD Ischemic heart disease
  2. a medical history prior to IE, b Native valve disease without prosthetic valve, c cardiac implantable electronic device